Novel Strategies for Detection, Diagnosis and Management of Non-small Cell Lung Cancer
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Pulmonology".
Deadline for manuscript submissions: 20 July 2024 | Viewed by 169
Special Issue Editors
2. Department of Surgery, Boston University School of Medicine, Boston, MA 02118, USA
Interests: surgical management of lung cancer; tumor biology of lung cancer; novel ways to screen for lung cancer
Special Issue Information
Dear Colleagues,
In this Special Issue, we aim to provide an overview of novel tools which aid in the management of non-small cell lung cancer. From a management standpoint, we hope to cover tools that could help in the detection, diagnosis and prognosis, as well as predictive markers of chemo/targeted/immune therapies. The tools encompass those developed from airway (breath print, airway epithelium), blood (liquid biopsy, cell-free DNA, molecular markers) and imaging (radiomics) data.
This Special Issue intends to bring together experts on detecting, diagnosing and managing non-small cell lung cancer, addressing all these aspects. We encourage submissions of original research or review articles that highlight the current progress, gaps in the field and future challenges, thereby promoting novel research on this topic.
Dr. Kei Suzuki
Dr. Janakiraman Subramanian
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- novel screening tool
- liquid biopsy
- radiomics
- predictive marker of immunotherapy
- non-small cell lung cancer
